Showing results (1-10 of 141) with videos related to
Sort By:
Pageof 15
Familial Cancer|June 23, 2010
Screening for large genomic rearrangements of the BRIP1 and CHK1 genes in Finnish breast cancer familiesSzilvia Solyom, Katri Pylkäs, Robert WinqvistBMC Medical Genetics|July 22, 2011
Mutation screening of the RNF8, UBC13 and MMS2 genes in Northern Finnish breast cancer familiesMikko Vuorela, Katri Pylkäs, Robert WinqvistCancer Letters|December 14, 2007
Germline alterations in the CLSPN gene in breast cancer familiesHannele Erkko, Katri Pylkäs, Sanna-Maria Karppinen, et al.BMC Cancer|December 4, 2014
Recurrent CYP2C19 deletion allele is associated with triple-negative breast cancerAnna Tervasmäki, Robert Winqvist, Arja Jukkola-Vuorinen, et al.BMC Medical Genetics|August 15, 2013
Evaluation of the need for routine clinical testing of PALB2 c.1592delT mutation in BRCA negative Northern Finnish breast cancer familiesMaria Haanpää, Katri Pylkäs, Jukka S Moilanen, et al.BMC Cancer|May 27, 2008
Analysis of large deletions in BRCA1, BRCA2 and PALB2 genes in Finnish breast and ovarian cancer familiesKatri Pylkäs, Hannele Erkko, Jenni Nikkilä, et al.BMC Cancer|December 23, 2009
Mutation analysis of the AATF gene in breast cancer familiesMaria Haanpää, Mervi Reiman, Jenni Nikkilä, et al.Biochemical and Biophysical Research Communications|July 29, 2025
PALB2 mutations increase oncogenic properties of breast epithelial cells by enhancing JAM3 and PARVB expressionHanna Tuppurainen, Marjut Nätynki, Niina Laurila, et al.Breast Cancer Research and Treatment|July 3, 2009
Mutation screening of the MERIT40 gene encoding a novel BRCA1 and RAP80 interacting protein in breast cancer familiesSzilvia Solyom, Jeffery Patterson-Fortin, Katri Pylkäs, et al.Plos Genetics|June 28, 2012
Rare copy number variants observed in hereditary breast cancer cases disrupt genes in estrogen signaling and TP53 tumor suppression networkKatri Pylkäs, Mikko Vuorela, Meeri Otsukka, et al.Pageof 15